Ex-OSTP Official Hopes To Influence Washington, Academe

Editor's Note: Biologist M.R.C. Greenwood has had a banner year. Last July, she was named chancellor of the University of California, Santa Cruz. A short time later, she was selected to serve on the National Science Board and was voted president-elect of the American Association for the Advancement of Science (AAAS). Greenwood 's new positions allow her to continue being involved in national science policy, a role she has been in since she served as associate director for science in the Office

Written bySteven Benowitz
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Editor's Note: Biologist M.R.C. Greenwood has had a banner year. Last July, she was named chancellor of the University of California, Santa Cruz. A short time later, she was selected to serve on the National Science Board and was voted president-elect of the American Association for the Advancement of Science (AAAS). Greenwood 's new positions allow her to continue being involved in national science policy, a role she has been in since she served as associate director for science in the Office of Science and Technology Policy (OSTP)from November 1993 to May 1995. One of her major policy contributions was serving as a member of the team that crafted the 1994 report "Science in the National Interest," which set post-Cold War science goals for the Clinton administration. They included raising scientific literacy, stimulating partnerships that promote investments in fundamental science and engineering, and raising the national R&D investment to some ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies